Basic information Safety Related Supplier
ChemicalBook >  Product Catalog >  API >  Antineoplastic agents >  Tinib Antineoplastic drugs >  17-AAG


Basic information Safety Related Supplier
17-AAG Basic information
17-AAG Chemical Properties
  • Melting point:201-203°C
  • Boiling point:797.8±60.0 °C(Predicted)
  • Density 1.21
  • RTECS LX8932000
  • Flash point:>110°(230°F)
  • storage temp. −20°C
  • solubility DMSO: soluble
  • pka8.62±0.70(Predicted)
  • form solid
  • Water Solubility Soluble in DMSO at 150 mg/mL; soluble in ethanol at 5 mg/mL. Very poorly soluble in water
  • Sensitive Light Sensitive
  • CAS DataBase Reference75747-14-7
Safety Information
17-AAG Usage And Synthesis
  • Chemical PropertiesDark Purple Solid
  • UsesPotent inhibitor of heat shock protein 90 (Hsp90). 17-AAG is a less toxic analog than Geldanamycin. It induces apoptosis and displays antitumor effects. 17-AAG inhibits the activity of oncogenic proteins such as N-ras, Ki-ras, c-Akt, and p185erB2.
  • UsesGeldanamycin is a potent inhibitor of Hsp90 that exhibits severe hepatotoxicity when used in vivo. 17-AAG is an analog of geldanamycin which has potent in vivo activity and reduced toxicity. Like other Hsp90 inhibitors, 17-AAG has diverse anti-tumor actions and has potential in treating certain types of cancer. 17-AAG inhibits the growth of prostate cancer cell lines (IC50 = 25-45 nM). 17-AAG promotes the degradation of HER2 and induces growth arrest and apoptosis in breast cancer cells overexpressing HER2 (IC50 = 4-72 nM).
  • DefinitionChEBI: A 19-membered macrocyle that is geldanamycin in which the methoxy substituent attached to the benzoquinone moiety has been replaced by an allylamino group. It is a potent inhibitor of heat shock protein 90 (Hsp90). A less toxic analogue than geldanamycin, t induces apoptosis and displays antitumour effects.
  • Biological ActivityInhibitor of heat shock protein 90 (Hsp90) chaperone activity, and an analog of geldanamycin (9,13-Dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-carbamate ). Subsequently inhibits the activity of oncogenic proteins such as p185 erbB-2 (IC 50 = 31 nM), N-ras, Ki-ras and c-Akt. Antitumor in vivo .
17-AAG(75747-14-7)Related Product Information
  • Company Name:J & K SCIENTIFIC LTD.
  • Tel:400-666-7788 010-82848833-
  • Company Name:3B Pharmachem (Wuhan) International Co.,Ltd.
  • Tel:18930552037 821-50328103-801
  • Company Name:Chembest Research Laboratories Limited
  • Tel:021-20908456-
  • Company Name:LGM Pharma
  • Tel:1-(800)-881-8210
  • Company Name:Chemsky(shanghai)International Co.,Ltd.
  • Tel:021-50135380